Compare AMAR REMEDIES with Bajaj Consumer Care - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CONSUMER CARE - Comparison Results

BAJAJ CONSUMER CARE 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CONSUMER CARE AMAR REMEDIES/
BAJAJ CONSUMER CARE
 
P/E (TTM) x -0.5 17.1 - View Chart
P/BV x 0.1 6.8 0.9% View Chart
Dividend Yield % 0.0 6.5 -  

Financials

 AMAR REMEDIES   BAJAJ CONSUMER CARE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CONSUMER CARE
Mar-19
AMAR REMEDIES/
BAJAJ CONSUMER CARE
5-Yr Chart
Click to enlarge
High Rs164510 32.2%   
Low Rs86308 27.9%   
Sales per share (Unadj.) Rs261.662.3 420.1%  
Earnings per share (Unadj.) Rs17.415.0 115.8%  
Cash flow per share (Unadj.) Rs22.315.5 143.7%  
Dividends per share (Unadj.) Rs014.00 0.0%  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs100.731.7 317.9%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.56.6 7.3%   
Avg P/E ratio x7.227.2 26.4%  
P/CF ratio (eoy) x5.626.4 21.3%  
Price / Book Value ratio x1.212.9 9.6%  
Dividend payout %093.2 0.0%   
Avg Mkt Cap Rs m3,27060,313 5.4%   
No. of employees `000NA1.3 0.0%   
Total wages/salary Rs m163972 16.8%   
Avg. sales/employee Rs ThNM7,289.5-  
Avg. wages/employee Rs ThNM771.2-  
Avg. net profit/employee Rs ThNM1,758.7-  
INCOME DATA
Net Sales Rs m6,8449,185 74.5%  
Other income Rs m21170 12.3%   
Total revenues Rs m6,8659,355 73.4%   
Gross profit Rs m1,1312,744 41.2%  
Depreciation Rs m12871 180.5%   
Interest Rs m39812 3,401.7%   
Profit before tax Rs m6262,832 22.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121616 19.7%   
Profit after tax Rs m4552,216 20.5%  
Gross profit margin %16.529.9 55.3%  
Effective tax rate %19.321.7 88.9%   
Net profit margin %6.624.1 27.6%  
BALANCE SHEET DATA
Current assets Rs m4,9044,250 115.4%   
Current liabilities Rs m3,5811,376 260.2%   
Net working cap to sales %19.331.3 61.8%  
Current ratio x1.43.1 44.3%  
Inventory Days Days12424 513.3%  
Debtors Days Days10015 674.2%  
Net fixed assets Rs m1,6891,769 95.5%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,526 52.1%   
Net worth Rs m2,6354,674 56.4%   
Long term debt Rs m5070-   
Total assets Rs m6,8626,052 113.4%  
Interest coverage x2.6243.0 1.1%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.5 65.7%   
Return on assets %12.436.8 33.8%  
Return on equity %17.347.4 36.4%  
Return on capital %31.060.8 51.0%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273123 221.9%   
Fx outflow Rs m226 7.8%   
Net fx Rs m27197 278.7%   
CASH FLOW
From Operations Rs m-3131,764 -17.7%  
From Investments Rs m-489686 -71.3%  
From Financial Activity Rs m769-2,384 -32.2%  
Net Cashflow Rs m-3362 -52.5%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   P&G HYGIENE  LINC PEN & PLASTICS  KARUTURI GLOBAL  COLGATE  EMAMI  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex, Nifty Open Higher; Bajaj Finance & UltraTech Cement Top Gainers(09:30 am)

Asian stock markets are trading on a strong note today. The Hang Seng is trading up by 2% while the Shanghai Composite is up 0.6%. The Nikkei is trading higher by 0.4%.

Related Views on News

BAJAJ CONSUMER CARE Announces Quarterly Results (2QFY21); Net Profit Down 0.1% (Quarterly Result Update)

Oct 19, 2020 | Updated on Oct 19, 2020

For the quarter ended September 2020, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (down 0.1% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE Announces Quarterly Results (3QFY20); Net Profit Down 16.7% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 501 m (down 16.7% YoY). Sales on the other hand came in at Rs 2 bn (down 7.9% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE Announces Quarterly Results (2QFY20); Net Profit Up 10.9% (Quarterly Result Update)

Oct 14, 2019 | Updated on Oct 14, 2019

For the quarter ended September 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (up 10.9% YoY). Sales on the other hand came in at Rs 2 bn (up 2.1% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE Announces Quarterly Results (1QFY20); Net Profit Up 9.1% (Quarterly Result Update)

Jul 17, 2019 | Updated on Jul 17, 2019

For the quarter ended June 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 587 m (up 9.1% YoY). Sales on the other hand came in at Rs 2 bn (up 8.5% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of BAJAJ CONSUMER CARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CONSUMER CARE. Also includes updates on the valuation of BAJAJ CONSUMER CARE.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS